Flossbach Von Storch’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268M Sell
1,096,864
-308,762
-22% -$71.9M 1.25% 25
2025
Q4
$291M Sell
1,405,626
-1,589,548
-53% -$314M 1.15% 27
2025
Q3
$555M Sell
2,995,174
-3,347,823
-53% -$574M 2.19% 18
2025
Q2
$969M Sell
6,342,997
-145,995
-2% -$22.4M 3.96% 7
2025
Q1
$1.08B Sell
6,488,992
-40,304
-0.6% -$6.31M 4.66% 4
2024
Q4
$944M Buy
6,529,296
+28,814
+0.4% +$4.47M 3.76% 7
2024
Q3
$1.05B Buy
6,500,482
+168,823
+3% +$26.9M 4.13% 6
2024
Q2
$925M Buy
6,331,659
+291,017
+5% +$43.3M 3.88% 7
2024
Q1
$956M Sell
6,040,642
-72,123
-1% -$11.5M 4.16% 9
2023
Q4
$958M Sell
6,112,765
-1,329
-0% -$204K 4.37% 8
2023
Q3
$952M Sell
6,114,094
-71,676
-1% -$11.8M 4.2% 7
2023
Q2
$1.02B Buy
6,185,770
+55,556
+0.9% +$8.97M 4.13% 7
2023
Q1
$950M Buy
6,130,214
+712,004
+13% +$115M 4% 6
2022
Q4
$957M Sell
5,418,210
-135,206
-2% -$23.3M 3.65% 5
2022
Q3
$907M Sell
5,553,416
-73,057
-1% -$12.4M 3.34% 6
2022
Q2
$999M Sell
5,626,473
-2,576,209
-31% -$459M 3.35% 6
2022
Q1
$1.45B Sell
8,202,682
-982,427
-11% -$167M 4.06% 4
2021
Q4
$1.57B Buy
9,185,109
+638,058
+7% +$104M 4.23% 5
2021
Q3
$1.38B Buy
8,547,051
+13,710
+0.2% +$2.34M 4.02% 7
2021
Q2
$1.41B Sell
8,533,341
-25,878
-0.3% -$4.28M 4.21% 8
2021
Q1
$1.41B Sell
8,559,219
-209,794
-2% -$33.9M 4.95% 5
2020
Q4
$1.38B Buy
8,769,013
+543,541
+7% +$80.2M 5.65% 5
2020
Q3
$1.22B Buy
8,225,472
+143,088
+2% +$21.2M 5.97% 5
2020
Q2
$1.14B Buy
8,082,384
+51,335
+0.6% +$7.48M 5.93% 6
2020
Q1
$1.05B Buy
8,031,049
+126,565
+2% +$18M 7.08% 5
2019
Q4
$1.15B Buy
7,904,484
+1,530,146
+24% +$208M 7.83% 3
2019
Q3
$825M Buy
6,374,338
+765,025
+14% +$101M 6.57% 5
2019
Q2
$781M Buy
5,609,313
+485,975
+9% +$67.3M 6.7% 5
2019
Q1
$716M Buy
5,123,338
+457,002
+10% +$61.2M 6.6% 5
2018
Q4
$602M Buy
4,666,336
+594,674
+15% +$83M 5.73% 5
2018
Q3
$563M Buy
4,071,662
+518,026
+15% +$68.8M 5.14% 7
2018
Q2
$431M Buy
3,553,636
+1,235,186
+53% +$154M 4.23% 7
2018
Q1
$297M Buy
2,318,450
+1,159,690
+100% +$157M 3.05% 10
2017
Q4
$162M Buy
1,158,760
+2,890
+0.3% +$403K 1.55% 21
2017
Q3
$150M Sell
1,155,870
-146,187
-11% -$19.4M 1.57% 20
2017
Q2
$172M Buy
1,302,057
+8,487
+0.7% +$1.08M 1.96% 18
2017
Q1
$161M Sell
1,293,570
-236,555
-15% -$28.3M 2.47% 13
2016
Q4
$176M Sell
1,530,125
-940,990
-38% -$109M 2.86% 12
2016
Q3
$292M Sell
2,471,115
-244,615
-9% -$29.7M 4.87% 7
2016
Q2
$329M Sell
2,715,730
-514,495
-16% -$58.5M 5.66% 6
2016
Q1
$350M Sell
3,230,225
-369,795
-10% -$38.3M 5.56% 5
2015
Q4
$370M Buy
3,600,020
+95,150
+3% +$9.57M 6.31% 3
2015
Q3
$327M Buy
3,504,870
+189,410
+6% +$18.3M 5.69% 6
2015
Q2
$323M Buy
3,315,460
+391,590
+13% +$39.2M 6.25% 5
2015
Q1
$294M Buy
2,923,870
+1,059,630
+57% +$108M 6.65% 3
2014
Q4
$195M Buy
1,864,240
+170,970
+10% +$18M 4.57% 7
2014
Q3
$180M Buy
1,693,270
+94,070
+6% +$9.76M 3.92% 8
2014
Q2
$167M Sell
1,599,200
-220,390
-12% -$22.3M 4.01% 7
2014
Q1
$179M Buy
1,819,590
+502,380
+38% +$46.6M 4.76% 7
2013
Q4
$121M Buy
1,317,210
+198,024
+18% +$18.2M 3.43% 12
2013
Q3
$97M Sell
1,119,186
-432,024
-28% -$38.8M 2.98% 13
2013
Q2
$133M Buy
+1,551,210
New +$132M 4.03% 9

Other funds holding JNJ

Flossbach Von Storch's JNJ Position: Q1 2026 in Review

Flossbach Von Storch reduced its Johnson & Johnson (JNJ) stake by 22% in Q1 2026, selling an estimated $71.9M and leaving 1,096,864 shares worth $268M. The position accounts for 1.25% of the portfolio, ranked #25.

Flossbach Von Storch first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.57B in Q4 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Flossbach Von Storch held 1,096,864 shares of Johnson & Johnson worth $268M as of Q1 2026.
  • Flossbach Von Storch sold 308,762 Johnson & Johnson shares in Q1 2026, an estimated $71.9M.
  • Johnson & Johnson made up 1.25% of Flossbach Von Storch's portfolio in Q1 2026, its #25 holding.
  • Flossbach Von Storch first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Flossbach Von Storch's Johnson & Johnson position peaked at $1.57B in Q4 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Flossbach Von Storch's 13F filing for Q1 2026, filed 29 Apr 2026.